These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 33031802)
1. Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application. Dudhipala N; Ali Youssef AA; Banala N Chem Phys Lipids; 2020 Nov; 233():104981. PubMed ID: 33031802 [TBL] [Abstract][Full Text] [Related]
2. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections. Dudhipala N; Ay AA Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effect of Ropinirole Lipid Nanoparticles Enriched Hydrogel for Parkinson's Disease: In Vitro, Ex Vivo, Pharmacokinetic and Pharmacodynamic Evaluation. Dudhipala N; Gorre T Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32414195 [TBL] [Abstract][Full Text] [Related]
4. Topical application of nanoparticles integrated supramolecular hydrogels for the potential treatment of seborrhoeic dermatitis. Garg A; Singh C; Pradhan D; Ghosh G; Rath G Pharm Dev Technol; 2020 Jul; 25(6):748-756. PubMed ID: 32149557 [TBL] [Abstract][Full Text] [Related]
5. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Jain S; Jain S; Khare P; Gulbake A; Bansal D; Jain SK Drug Deliv; 2010 Aug; 17(6):443-51. PubMed ID: 20486871 [TBL] [Abstract][Full Text] [Related]
6. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization. Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427 [TBL] [Abstract][Full Text] [Related]
7. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Aljaeid BM; Hosny KM Int J Nanomedicine; 2016; 11():441-7. PubMed ID: 26869787 [TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation. Dudhipala N; Janga KY Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147 [TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Bhaskar K; Anbu J; Ravichandiran V; Venkateswarlu V; Rao YM Lipids Health Dis; 2009 Feb; 8():6. PubMed ID: 19243632 [TBL] [Abstract][Full Text] [Related]
10. Formulation evaluation of ketoconazole microemulsion-loaded hydrogel with nigella oil as a penetration enhancer. Amra K; Momin M J Cosmet Dermatol; 2019 Dec; 18(6):1742-1750. PubMed ID: 30980617 [TBL] [Abstract][Full Text] [Related]
11. Influence of formulation variables on miconazole nitrate-loaded lipid based nanocarrier for topical delivery. Al-Maghrabi PM; Khafagy ES; Ghorab MM; Gad S Colloids Surf B Biointerfaces; 2020 Sep; 193():111046. PubMed ID: 32416518 [TBL] [Abstract][Full Text] [Related]
12. SLN and NLC for topical delivery of ketoconazole. Souto EB; Müller RH J Microencapsul; 2005 Aug; 22(5):501-10. PubMed ID: 16361193 [TBL] [Abstract][Full Text] [Related]
13. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite. Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163 [TBL] [Abstract][Full Text] [Related]
14. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Ansari H; Singh P Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641 [TBL] [Abstract][Full Text] [Related]
15. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Garg A; Singh S Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909 [TBL] [Abstract][Full Text] [Related]
16. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. Aggarwal N; Goindi S J Biomed Nanotechnol; 2013 Apr; 9(4):564-76. PubMed ID: 23621015 [TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
19. Prolonged Skin Retention of Luliconazole from SLNs Based Topical Gel Formulation Contributing to Ameliorated Antifungal Activity. Kaur M; Singh G; Shivgotra R; Singh M; Thakur S; Jain SK AAPS PharmSciTech; 2024 Oct; 25(7):229. PubMed ID: 39354184 [TBL] [Abstract][Full Text] [Related]
20. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]